LENSRXLAB Secures $830,000 to Develop Two B2B Healthcare Delivery Platforms and Advanced Lens Technology for Diabetics

PHILADELPHIA & JACKSONVILLE, Fla.–(BUSINESS WIRE)–#diabeticeyewear–Ophthalmic Goods Manufacturing startups Bon Vivant Safety Eyewear Company, Inc. and Tioga Optical Lab QOZB, LLC, founded by Anthony B. Miles, US Navy Trident Nuclear Submarine Force Veteran and Dr. Chelise Firmin, Optometrist, has secured $830,000 in seed funding for the joint venture LENSRXLAB to develop two B2B Healthcare Delivery Platforms and a proprietary Advanced Lens Technology for Diabetics.


Now the duo collectively seeks to raise $3.1 million. The funds will be used to go to market with their two B2B Healthcare Delivery Platforms at scale, production of inventory, hiring key staff and equity toward the build-out and automated production equipment for its 18,629-sf ground-up manufacturing facility to be built adjacent to Temple University Health Sciences Campus in Philadelphia, Pennsylvania to service all 48 U.S. States–Alaska, Hawaii, and U.S. territories (Puerto Rico, Guam, Northern Mariana Islands, U.S. Virgin Islands and American Samoa).

Their B2B offerings include LENSRXLAB’s groundbreaking online Supplemental Vision Benefits Platform for Diabetics. Tailored for Hospitals and Medical Clinics, Health Insurance Companies, Corporate Employers, Military/Veteran Organizations, Diabetic Care Centers, Health Programs, and Others, LENSRXLAB offers a new approach with its comprehensive all-in-one single vision, bifocal and progressive diabetic eyewear packages, ensuring accessibility for patients, service members, veterans, beneficiaries, and employees.

One new innovation by the duo is DiaVista, a proprietary advanced lens technology powered by Nirtech® with 7 lights with UV + IR protection to be offered through both LENSRXLAB B2B platforms and globally through strategic partners.

“Our all-in-one diabetic packages represent a holistic approach to vision care, addressing not just visual needs but also prioritizing the medical aspects of diabetic eye health. By integrating advanced technologies and medical-grade materials, we aim to provide comprehensive solutions that promote eye wellness and enhance quality of life for individuals, men, women, and children managing diabetes,” said Dr. Chelise Firmin, Optometrist, Founder of LENSRXLAB.

LENSRXLAB is also planning to expand its offerings with new products, services, and programs, including The DiaVista Gift Voucher Pilot Program for Diabetic Vision Equity. This program’s annual goal, with the support of corporate sponsors and donors, is to provide fully subsidized, specialized prescription diabetic eyewear packages with its proprietary DiaVista Advanced Lens Technology to over 20,000 low-income individuals, seniors, and veterans.

Additionally, we plan to introduce an advanced Computer Lens featuring blue light blocking technology to prevent eye strain from everyday digital devices. With 99% light transmission and 99% blocking of HEV radiation, along with 91% blocking of infrared radiation, this lens aims to enhance visual comfort and protect eye health in our increasingly digital world.

Furthermore, we are launching an animated cartoon series called LENS LEGENDS, weaving together elements of adventure, humor, and education to entertain audiences of all ages while addressing various social determinants of health.

With the infusion of $3.1 million in funding, LENSRXLAB is poised for remarkable growth and innovation in the diabetic vision care sector. By leveraging this funding to enhance its offerings, expand its reach, and build out its future ophthalmic goods manufacturing facility, LENSRXLAB is primed to revolutionize diabetic eyewear, empowering individuals to manage diabetes with cutting-edge technology and comprehensive vision care.

To learn more about LENSRXLAB, please visit the www.diavistalenstech.com

About LENSRXLAB

LENSRXLAB is a distinguished Black American and SBA Service-Disabled Veteran-Owned Ophthalmic Goods Manufacturer and Wholesaler Small Business Enterprise. Specializing in prescription safety, diabetic, and dress eyewear, our brands include two B2B Healthcare Delivery Platforms: the LENSRXLAB Supplemental Vision and Health Benefits Platform for Government and Corporate Worksites, and the LENSRXLAB Supplemental Vision Benefits Platform for Diabetics. Additionally, we offer our proprietary DiaVista Advanced Lens Technology for Diabetics. Our target customers include Federal, State & Municipal Agencies, Military Establishments, Corporate Worksites, Hospitals & Clinics, Health Insurance Companies, Health Programs, and more. Led by Anthony B. Miles, a US Navy Trident Nuclear Submarine Force Veteran, and Dr. Chelise Firmin, Optometrist, our leadership is rooted in Philadelphia, Pennsylvania, with operations extending to Jacksonville, Florida.

Contacts

[email protected]
904-325-9930

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.